• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "July, 2023"
 Benzinga: Why NBIO is a Biotech Bargain Basement Deal with Underappreciated Potential
0
By Nascent Biotech
In Science News
Posted July 12, 2023

Benzinga: Why NBIO is a Biotech Bargain Basement Deal with Underappreciated Potential

We came across Nascent Biotech Inc. NBIO last year and it caught our eye despite still trading on the OTC for just pennies per share. The share price of a stock isn’t a very important [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.